Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medtronic recalls selected heparin-coated CPB products

Medtronic : 08 May, 2008  (Company News)
Medtronic is initiating a voluntary and precautionary recall of selected products featuring the Carmeda BioActive surface.
The affected devices are disposable products used during cardiopulmonary bypass (CPB) for heart surgeries. Affected products include blood oxygenators, reservoirs, pumps, cannulae, and tubing packs.

The action is being taken following the US Food and Drug Administration’s April 8, 2008 recommendation to device manufacturers that heparin supplies be checked with newly­developed tests, and that affected products be evaluated for possible field corrective action. Limited lots of Carmeda­coated products were manufactured with heparin found to have been contaminated with oversulphated chondroitin sulphate (OSCS).

The patient risk associated with the presence of OSCS in heparin­coated medical devices is not known at this time. However, the US Food and Drug Administration has received reports of serious injury and death in patients who have been administered injectable heparin products containing high levels of OSCS.

Medtronic has not received reports of any OSCS­related adverse events arising from the use of Carmeda CPB products. It is unclear, however, if exposure to Carmeda­coated medical devices, made with comparatively small amounts of heparin, could cause adverse events similar to those observed with injectable heparin formulations.

As a result, Medtronic has initiated a precautionary recall of affected Carmeda products. In a separate action, Medtronic is advising customers that selected lots of Trillium­coated products were also manufactured with heparin containing OSCS. Trillium is another biosurface used on CPB products. The amount of heparin on the product is significantly lower than that contained on the Carmeda product.

Medtronic’s ultimate goal is to remove contaminated products from the market. However, based on the current data, the benefit of using the affected products outweighs any potential risk to patients. Since the maximum possible patient exposure to heparin from Trillium is extremely low, customers can continue to use the affected Trillium products until a replacement is available.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo